Ovarian oncology Flashcards

1
Q

why do ovarian cancers tend to have worse prognosis

A

present late due to non-specific symptoms

  • > 70% of ptx present after it has spread beyond the pelvis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how can ovarian tumours be classified 4

A

eipthelial cell tumours

dermoid cysts/ Germ cell tumours

sex cord-stromal tumours

metatsis from other tumour sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the most common ovairian tumour type

A

epithelial cell tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

subtypes of epithelial cell ovarian tumours 5

A

serous tumours (most common)

endometrioid carcinomas

clear cell tumours

mucinous tumours

undifferentiated tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are dermoid cyst/germ cell tumours benign or malignant

A

benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what can dermoid cyst/germ cell tumours include 4

A

various types of tissue such as skin, teeth, hair and bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are dermoid cyst/germ cell tumours associated with 1

A

ovarian torsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what biochemical markers are dermoid cyst/germ cell tumours associated with 2

A

raised alpha-fetoprotein (å-FP)

raised human chorionic gonadotrophin (hCG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do sex cord-stromal ovarian tumours arise from 2

A

sex cords - embyronic structures assocaited with the follicles

stroma - connective tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

main types of sex cord-stromal ovarian tumours 2

A

sertoli-leydig cell tumours

granulosa cell tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is a common metatsis to the ovaries and the name of the tumour

A

Krukenberg tumour
-usuusually from a GI tract cancer (particularly the stomach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

characterisitc finding in krukenberg tumours 1

A

‘signet-ring’ cells on histology
-look like signet rings under a microscope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

risk factors for ovarian tumours 6

A

age (peak age 60)

BRCA1 and BRAC2 genes (consider FHx)

increased No of ovulations

obesity

smoking

recurrent use of clomifene (infertility drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What else can impact the risk of ovarian cancer
-give some examples 3

A

increased number of ovulations-> incresed risk of ovarian cancer

examples
-early-onset periods
-late menopause
-no pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is a protective factor for ovarian cancer
-give some examples 3

A

factors that stop ovulation or reduce the number of lifetime ovulations-> reduce the risk of ovarian ca

examples
-combined contraceptive pill
-breastfeeding
-pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is important when assessing someone with a potential ovarian cancer

A

often presents with very non-sepcific syx

-in older women keep the possibility of ovarian cancer in mind and have a low threshold for considering further investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

symptoms of ovarian cancer 8

A

abdo bloating

early satiety (feeling full after eating)

loss of appetite

pelvic pain

urinary syx - frequency / urgency

weight loss

abdo or pelvic mass

ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what can an ovarian mass compress and how does this manifest as symptoms

A

can press on the obturator nerve and cause referred hip or groin pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what symptoms after examination would prompt a direct 2-week-wait referral for ovarian cancer 3

A

ascites

pelvic mass -unless clearly due to fibroids

abdominal mass

20
Q

what is the most important initial investigation in a possible ovarian cancer?

A

CA125 blood test

21
Q

what other investigation is important for possible ovarian cancer 1

A

pelvic ultrasound

22
Q

what is used to estimate the risk of an ovarian mass being malignant 1

A

risk of malignancy index (RMI)

23
Q

what does the risk of malginancy index take into account when identifying if an ovarian mass is malignant 3

*-what is the calculation

A

menopausal status

ultrasound findings

CA125 levels

*-RMI= UxMxCA125

24
Q

what ultrasound findings are used in the risk of malignancy index for ovarian cancer

-what is the menopausal status score

A

Multilocular
Solid areas
Ascites
Intra abdominal metastasis
Score
0 = 0
1 = 1
2/+ = 3

  • 1- pre
    3- post
25
an example risk of malgnancy index calculation for ovairna cancer
Example 60y, Postmenopausal, CA125 is 300, Bilateral complex ovarian masses, solid areas, ascites. Therefore RMI = U3 X M3 X 300 = 2700
26
what value of the risk malginacy index is used to indicate a probable malignancy in ovarian cancer
RMI >200
27
further investigaitons in secondary care for ovarian cancer 3
CT scan -establish diagnosis and stage the cancer histology (tissue sample) -using a CT guided biopsy, laparoscopy or laparotomy paracentesis (ascitic tap) -can be used to test the ascitic fluid for cancer cells
28
what investigations are important for a COMPLEX OVARIAN MASS in women UNDER 40 (2)
check for possible germ cell tumours so -alpha-fetoprotein (å-FP) -human chorionic gonadotropin (HCG)
29
what non-malignant causes of a raised CA125 can be found 6
endometriosis fibroids adenomyosis pelvic infection liver disease pregnancy
30
regarding staging ovarian cancer define stage 1
confined to ovary
31
regarding staging ovarian cancer define stage 2
spread past ovary but inside the pelvis
32
regarding staging ovarian cancer define stage 3
spread past pelvis but inside the abdomen
33
regarding staging ovarian cancer define stage 4
spread outside the abdomen (distant metastasis)
34
how can types of epithelial ovarian cancer be split
2 types high grade serous or arise from ovarian surface epithelium and Mullerian inclusion cysts
35
what do high grade serous epithelial ovarian tumours resemble
fallopian tube mucosa
36
what genetic mutations are found in high grade serous epithelial ovarian tumours
P53
37
what types of epithelial ovarian cancer arise from ovarian surface epithelium and mullerian inclusion cysts 4
endometriod clear cell mucinous low grade serous
38
how do ovarian cancers spread 3
direct extension (transcoelemic) exfoliation into the peritoneal cavity lymphatic invasion
39
screening for ovarina cancer
current trials but no evidence so far to support screening even in high risk women
40
ovarian cancer gene mutations 3
BRCA1- chromosome 17q BRAC2 chromosome 13q lynch syndrome -HNPCC -mutation in mismatch repiar genes *-also undiscovered genes
41
what cancer preentations suggest famial cause due to BRCA 1, BRCA2 and HNPCC 3
early onset breast cancer <50y male breast cancer bilateral breast cancer
42
what risk reducing surgery is available for high risk ovarian cancer patients *-what reduction in risk does this cause 2
prophylatic bilateral salpingo-oophrectomy -important to remove ovary AND entire fallopian tube *- 96% ovarian ca reduction -53% breast ca reduction
43
what value of the risk malginacy index is used to indicate a probable malignancy in ovarian cancer
RMI >200
44
overview of ovarian cancer managment. 4
all cases discussed at MDT -guides investigations eg biopsies -decison on management chemo-timing?, drugs? surgery- appropriate?, timing?, by whom?
45
surgery overview of ovarina cancer
midline laparotmy -TAH, BSO, Washings, Omentectomy +/- appendicetomy / resection of peritoneal deposits Ultra-radical – splenectomy, bowel resection, peritoneal stripping Aim to leave NO residual disease or OPTIMAL CYTOREDUCTION (less than 1cm)
46
chemo overview of ovarian cacner
neo adjuvant -in patients with advanced disease -poor perfomarance status adjuvant -post op MDT decison 1st line include platinum agent in combo -carboplatin -paclitaxel in combo *intraperitoneal as part of clinical trials
47
other opitnos for ovarian cancer managemnt 2
biological agent s -antiangiogenesis hormonal therapy -tamoxifen/ aromatase inhibiotr